Biofrontera Inc. (BFRI)

Biofrontera Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	4.66	6.39	5.91	1.34	17.21	24.55
Short-Term Investments	0.01	0.01	0.01	0.08	10.55	-
Cash & Short-Term Investments	4.67	6.4	5.91	1.42	27.76	24.55
Cash Growth	-35.61%	8.27%	316.05%	-94.88%	13.08%	203.78%
Accounts Receivable	5.55	7.29	5.32	5.16	3.75	3.78
Other Receivables	0.31	1.9	0.06	-	-	11.91
Receivables	5.86	9.2	5.37	5.16	3.75	15.69
Inventory	1.1	1.43	6.65	10.91	7.17	4.46
Prepaid Expenses	0.16	0.32	0.23	0.43	0.44	0.82
Other Current Assets	0.66	0.74	2.54	5.16	4.03	0.91
Total Current Assets	12.44	18.08	20.7	23.08	43.14	46.42
Property, Plant & Equipment	4.95	3.74	0.98	1.75	1.58	0.27
Other Intangible Assets	2.57	2.65	0.04	2.63	3.03	3.45
Other Long-Term Assets	4.11	4.09	0.38	0.48	3.13	3.08
Total Assets	24.06	28.56	22.1	27.93	50.88	53.22

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	5.36	6.67	7.2	8.91	2.39	0.74
Accrued Expenses	3.8	4.17	3.12	3.5	4.49	3.4
Short-Term Debt	-	-	-	3.9	-	-
Current Portion of Leases	0.47	0.33	0.55	0.69	0.5	-
Other Current Liabilities	0.91	0.73	1.16	1.09	13.52	9.7
Total Current Liabilities	10.54	11.9	12.02	18.09	20.89	13.84
Long-Term Debt	4.62	4.59	4.1	-	-	-
Long-Term Leases	2.41	1.24	0.28	0.8	0.85	-
Other Long-Term Liabilities	0.54	0.36	1.27	4.25	5.26	28.05
Total Liabilities	18.11	18.08	17.67	23.14	27.01	41.88

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	0.01	0.01	0.01	0	0	0
Additional Paid-In Capital	139.24	138.41	121.83	104.44	103.4	90.22
Retained Earnings	-133.3	-127.95	-117.41	-99.65	-79.52	-78.88
Shareholders' Equity	5.96	10.48	4.43	4.79	23.88	11.34
Total Liabilities & Equity	24.06	28.56	22.1	27.93	50.88	53.22

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	7.5	6.16	4.92	5.4	1.35	-
Net Cash (Debt)	-2.84	0.24	0.99	-3.98	26.41	24.55
Net Cash Growth	-	-75.76%	-	-	7.60%	203.78%
Net Cash Per Share	-0.24	0.02	0.18	-2.57	24.99	55.73
Filing Date Shares Outstanding	14.85	11.65	8.87	5.09	1.37	0.86
Total Common Shares Outstanding	14.21	11.65	8.87	1.52	1.33	0.86
Working Capital	1.89	6.19	8.68	4.99	22.25	32.59
Book Value Per Share	0.42	0.90	0.50	3.16	17.89	13.26
Tangible Book Value	3.39	7.83	4.4	2.16	20.85	7.89
Tangible Book Value Per Share	0.24	0.67	0.50	1.43	15.62	9.22
Machinery	2.4	2.43	0.33	-	0.32	0.28
Leasehold Improvements	0.01	-	0.37	-	0.37	0.37

SEC Filings: 10-K · 10-Q

Data Source: S&P Global Market Intelligence Last updated: May 14, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 31, 2026

Data Sources Report a data error